These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 1907100)

  • 1. Availability of dideoxyinosine.
    Goldspiel BR
    Am J Hosp Pharm; 1991 Jun; 48(6):1299-300. PubMed ID: 1907100
    [No Abstract]   [Full Text] [Related]  

  • 2. The didanosine Expanded Access Program: safety analysis.
    Pike IM; Nicaise C
    Clin Infect Dis; 1993 Feb; 16 Suppl 1():S63-8. PubMed ID: 8425020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of patients with advanced HIV infection and zidovudine intolerance with dideoxyinosine.
    Pottage JC; Benson CA; Sha BE; Urbanski P; Kessler HA
    AIDS; 1992 Jul; 6(7):748-9. PubMed ID: 1503699
    [No Abstract]   [Full Text] [Related]  

  • 4. Drugs for HIV infection.
    Med Lett Drugs Ther; 1990 Feb; 31(811):11-3. PubMed ID: 2153901
    [No Abstract]   [Full Text] [Related]  

  • 5. The administration of didanosine (ddI) in the adult: a nursing perspective.
    Vaccariello J; Funesti JC; Laverty MK; Vasquez M; Curran-Krikorian K
    J Assoc Nurses AIDS Care; 1993; 4(1):23-9. PubMed ID: 8481500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hydroxyurea and didanosine is a more potent combination than hydroxyurea and zidovudine.
    Foli A; Lori F; Maserati R; Tinelli C; Minoli L; Lisziewicz J
    Antivir Ther; 1997 Jan; 2(1):31-8. PubMed ID: 11322264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Current developments in antiviral chemotherapy. Part 4: Foscarnet, zidovudine, didanosine].
    Stamminger T; Fleckenstein B
    Fortschr Med; 1994 May; 112(13):190-1. PubMed ID: 8020860
    [No Abstract]   [Full Text] [Related]  

  • 8. Once versus twice daily administration of didanosine in children with symptomatic HIV-associated disease who were intolerant to or clinically deteriorated on zidovudine. The Italian Pediatric Collaborative Study Group on Didanosine.
    Marchisio P; Principi N; Gabiano C; Galli L; Gattinara GC; Caselli D; Zuccotti G; La Regina A; Paga C
    Antivir Ther; 1997 Jan; 2(1):47-55. PubMed ID: 11322266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [HIV infection--current possibilities in antiviral therapy].
    Hirschel B
    Ther Umsch; 1994 Aug; 51(8):545-50. PubMed ID: 7940411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current perspectives on antiretroviral therapy.
    Fletcher CV
    Pharmacotherapy; 1993; 13(6):627-33. PubMed ID: 7508101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of zidovudine compared with didanosine on health status and functioning in persons with advanced HIV infection and a varying duration of prior zidovudine therapy. AIDS Clinical Trials Group 116/117 Study Group.
    Bozzette SA; Kanouse DE; Duan N; Berry S; Richman DD
    Antivir Ther; 1996 Jan; 1(1):21-32. PubMed ID: 11322256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Didanosine once daily: an overview.
    Youle M
    Antivir Ther; 1998; 3 Suppl 4():35-7. PubMed ID: 10723507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies of zidovudine in combination with didanosine and zalcitabine.
    Jablonowski H
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995; 10 Suppl 1():S52-6. PubMed ID: 8595509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined drugs may be better than zidovudine alone for immunocompromised adults infected with HIV-1.
    Commun Dis Rep CDR Wkly; 1995 Oct; 5(42):209. PubMed ID: 7496435
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmacotherapy of HIV. APhA Editorial Board on Pharmaceutical Care for Patients with HIV Infection.
    Am Pharm; 1994 Feb; NS34(2):60-9; quiz 69-70. PubMed ID: 8166046
    [No Abstract]   [Full Text] [Related]  

  • 16. [Once-daily administration of didanosine in combination with anti-retroviral zidovudine in previously untreated patients].
    Reynes J; Montes B; Delmas B; Vendrell JP; Janbon F; Segondy M
    Pathol Biol (Paris); 1997 May; 45(5):441-4. PubMed ID: 9296101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Results of the ALBI trial: a randomized comparison of stavudine/didanosine, zidovudine/lamivudine and alternating treatment in antiretroviral-naive patients.
    Molina JM; Chêuc G; Ferchal F; Journot V; Pellegrin I; Sombardier MN; Rancinan C; Cotte L; Madelaine I; Debord T; Decazes JM;
    Antivir Ther; 1999; 4 Suppl 3():71-4. PubMed ID: 16021874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of combined zidovudine and didanosine therapy in early asymptomatic primary HIV-1 infection.
    Khajotia RR; Feigley CE; Lee E; Gu J
    AIDS; 1998 Jan; 12(2):222-4. PubMed ID: 9468376
    [No Abstract]   [Full Text] [Related]  

  • 19. Meta-analysis of five randomized controlled trials comparing continuation of zidovudine versus switching to didanosine in HIV-infected individuals.
    Raboud JM; Montaner JS; Rae S; Kahn J; Hammer SM; Katzenstein DA; Pavia A; Dolin R; Hughes MD; Cross A; Beltangady M; Gatell J; Dunkle L; Smaldone L
    Antivir Ther; 1997 Dec; 2(4):237-47. PubMed ID: 11327443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leukocytopenia due to zidovudine- and nevirapine-containing regimens in elderly patients with HIV infection.
    Yamamoto Y; Yasuoka A; Yasuoka C; Genka I; Teruya K; Kikuchi Y; Tachikawa N; Oka S
    Jpn J Infect Dis; 2000 Dec; 53(6):244-5. PubMed ID: 11227023
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.